
Samika 250 Injection
Marketer
Ultratech Pharmaceuticals
Salt Composition
Amikacin (250mg)
Overview Samika 250 Injection
Cefazolin 250mg Injection combats a broad spectrum of bacterial infections, including those affecting the urinary tract, musculoskeletal system, respiratory system (such as pneumonia), central nervous system, and bloodstream. Prophylactic use is also common in hospitalized individuals. This antibiotic inhibits bacterial growth and is administered intravenously (IV infusion) or intramuscularly by a healthcare professional; self-administration is strictly prohibited. Adherence to the prescribed dosage schedule, with evenly spaced intervals, is crucial. Complete the entire course of treatment, even with symptom improvement, to prevent relapse. Premature cessation may result in infection recurrence or exacerbation. Commonly reported adverse effects include injection site reactions and elevated blood urea nitrogen (BUN) levels. Persistent side effects or lack of therapeutic response warrant immediate medical consultation. High-dose therapy may exceptionally cause vertigo, nephrotoxicity, and ototoxicity. Therefore, diligent adherence to physician instructions, including potential monitoring via renal function tests, audiometry, and urinalysis, is essential. Pregnancy is a contraindication. Disclose pregnancy, pregnancy plans, or breastfeeding to your physician.
Uses of Samika 250 Injection
Infections caused by bacteria
Major Benefits of Samika 250 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Samika 250 Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Samika 250 Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Samika 250 Injection works:
Samika 250 Injection is a bacterial growth inhibitor, functioning as an antibiotic by blocking the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse interactions between Samika 250 Injection and alcohol consumption.
PregnancyCONSULT YOUR DOCTOR
Administering Samika 250 Injection during pregnancy carries a confirmed risk to the fetus. Nevertheless, in exceptional life-threatening circumstances, a physician might deem its use justified if the potential advantages outweigh the inherent dangers. Seek medical advice before use.
Breast feedingSAFE IF PRESCRIBED
Administration of Samika 250 Injection while breastfeeding is considered safe. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Administering Samika 250 Injection might reduce attentiveness, impair vision, or induce drowsiness and dizziness. Refrain from operating a vehicle if these effects manifest.
KidneyCAUTION
Caution is advised when administering Samika 250 Injection to individuals with impaired renal function. Dosage modification for Samika 250 Injection might be necessary. Physician consultation is recommended.
LiverSAFE IF PRESCRIBED
The use of Samika 250 Injection in individuals with hepatic impairment is likely safe. Preliminary evidence indicates dose modification may be unnecessary. Physician consultation is recommended.
What if you forget to take Samika 250 Injection :
Should you forget a scheduled Samika 250 Injection, seek your physician's advice.
Facts to Know About Samika 250 Injection
| Label | Value |
|---|---|
| Chemical Type | Aminoglycoside antibiotics |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Action Category | Aminoglycoside antibiotics |
